Molekule Consulting (“Molekule”) is a recognized global leader in the development and refinement of primary competitive insights and intelligence for the biopharmaceutical and life sciences industries. Molekule aligns intelligence outcomes, focuses results and enables our client partners the ability to “win” in the highly dynamic and competitive biopharmaceutical space. Engaging with biopharmaceutical companies to provide accurate and actionable intelligence, Molekule Consulting remains a trusted partner of biopharmaceutical players today and tomorrow.
Lifescience Dynamics Limited is a specialist in primary human intelligence providing new intelligence – i.e. not known to our clients previously. Clients hire us to collect ‘high value intelligence’ which may impact on their strategic decisions. Our clients expect to receive “hard intelligence” which is not in the public domain, which is not written or published anywhere and certainly not available through any commercial databases.
Since 1992, trusted experts in primary regulatory, commercial and clinical CI research across 14 therapy areas and medical devices in N. America, Europe, APJ and LatAm – strong emerging market presence:
• Unique, best-in-class regulatory intelligence practice
• Systematic CI tracking programs
• Innovative competitor simulation workshops
• Strategic scenario planning workshops
• Strategic market opportunity/threat assessments
• Seasoned conference coverage methodologies
• Sensitive data leakage assessments & counter-intelligence seminars.
Atacana Group, Inc. is a new generation provider of competitive intelligence and strategy products for the pharmaceutical industry.
We deliver superior insights and a unique partnership by providing you with:
• A trusted cross-functional team with experience working in Pharma companies
• An innovative CI approach using Agile methodologies and digital tools
• A high-quality product through proven CI principles and processes
Our strength is managing large programs supporting:
• Potential blockbuster products that are in Phase 3 or that have recently launched
• Blockbuster products that are launching new indications
Our products include Ongoing Monitoring, Conference Insights, Deep Dives and CI Alerts.
AdisInsight is an easy-to-use database that helps you make better informed strategic decisions. A single search in the platform delivers highly-focused results from across the whole drug lifecycle allowing you to quickly see the big picture of a drug/disease landscape with interlinked information about drugs, trials, deals, safety and patents.
AlphaSense provides a revolutionary AI-based market intelligence search engine for corporations and investment firms. Our platform combines clients’ internal content with the world’s most valuable business and market information including broker research, call transcripts, company reports, news and trade journals. Seamlessly aggregating thousands of data sources, our groundbreaking semantic search engine captures variations in human language, accurately recognizing millions of business and financial terms and their synonyms, as well as companies, industries, topics and trends. Leveraging AlphaSense, corporations and financial firms make confident, quick decisions, enabling them to win in their markets. Used globally by more than 1,000 enterprise customers, AlphaSense is headquartered in New York with offices in London, Helsinki, India, and across the US.
Borderless Access Health is a unified end-to-end primary market research, data analytics and consulting service provider for global healthcare ecosystem. It provides world-class synergy of primary market research, business intelligence reporting and analytics services to global pharma, biotech, medical devices, payer and provider segment delivering real-time business insights for healthcare stakeholders in data driven decision making.
Our differentiation is our proprietary healthcare digital panels which has designed access of multi-dimensional reach for speciality physicians, healthcare professional (HCP), allied health professionals (AHPs), pharmacist, medical technologist, patients, care givers and insurance experts. This healthcare panel network spans across 80+ markets with 1.2 million+ patients community and 700,000+ physician networks globally.
We bring in extensive domain experience across 150+ therapy areas (including rare diseases) executing multi-country projects/engagments for 60+ clients for developed (North America, 5 EU, Japan) developing (LATAM, APAC, OCEANIA, Middle East) and challenging (Africa) markets.
Our unique business proposition helps clients to maximise return-on-insights and optimize costs for Real-time Intelligence (Primary market research), Real-world solutions (secondary research & analytics), Digitized business intelligence & reporting along with Market access and Health Economics and outcomes Research (HEOR) services.
Awarded with ‘ESOMAR Research Effectiveness Award – GOLD, 2021’; Best Partner Paper Award at PAMRO 2019; ‘Red Herring 100 Global, 2018’; ‘Red Herring 100 Asia, 2017’ and ‘Research Company of the Year’ at MRMW awards 2017 in Chicago; Borderless Access is a certified ‘Great Place to Work’ and is affiliated with leading market research governing bodies such as ESOMAR, AMA, MRA, Insights Association, Intellus, EphMRA, AMSRS, BHBIA, PAMRO, P&A.
Borderless Access values data security, privacy, and confidentiality and is an ISO 27001:2013 certified and GDPR & CCPA compliant company.
Learn more about our services and credentials on our website – www.borderlessaccess.com/ba-health
CHR works exclusively with companies in the life science sector, from the world’s largest biopharmaceutical companies, through to one-asset start-ups, providing strategic decision support, action planning and competitive intelligence, in addition to tailored landscape analyses, commercial opportunity assessments, market modelling and product sales forecasting. Our evaluation of market-player activity, intent and capabilities, combined with a targeted understanding of key trends in prescriber, regulator, and payer environments, enables our clients to make key decisions from an optimally informed position.
Course5 Intelligence is a premium solutions partner to the world’s leading pharmaceutical and biotech companies. We bring a multipronged approach to transforming scattered information about your competitors, customers and other important stakeholders (HCPs, payers and caregivers) into relevant, accurate and actionable strategic intelligence. Our solutions are driven through primary and secondary competitive intelligence including conference coverage, social media analysis, data analytics and digital platforms.
To learn more, visit https://www.course5i.com/life-sciences/
Deallus is a unique strategic intelligence consultancy operating across the global life sciences sector. Our mission is simple: to prepare you for the future by delivering the forward-thinking assurance you need in an uncertain and highly competitive world. The knowledge and clarity we provide helps life sciences companies shape future markets by making the right strategic decisions with confidence.
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. We support companies by providing end to end comprehensive solutions to improve their performance and in making long lasting decision for their businesses.
We advise leading decision makers on their critical issues and opportunities; Research & Development, Strategy Making, Commercial, Operations, Competitive Intelligence, Competitive Landscaping and Mergers & Acquisition across all the Pharma and Biotech industries and geographies. We serve our clients by delivering practical and enduring results, and equipping our clients to grow and lead.
Eleven years ago Beth Elliott & Tony Nagle created Dig Worldwide; The Primary Intelligence Company. Their aim is to provide high quality, focused, ethically sourced intelligence. Based out of the UK and working globally, the Dig team rely on hard work, tenacity and lateral thinking to uncover clients’ intelligence needs.
Since 1988, Fletcher/CSI, a leading global life-science consulting and research company, provides life sciences companies with in-depth primary research and competitive deep dives, War Game and Scenario Planning strategy session development and facilitation, medical congress and trade show data collection, and Win/Loss sales evaluations. Fletcher/CSI’s customized consulting services allows Senior, Brand, Business Development and Strategic Planning managers to make better decisions that maximize revenues, identify market opportunities that lead to further revenue growth and anticipate competitor actions. Fletcher/CSI’s experienced pharmaceutical brand consulting, research and medical specialists team combines both life science business acumen with therapeutic expertise to deliver in-depth insight and analysis into current and future market and competitor events and trends. Fletcher/CSI, headquartered in Williston, Vermont has global primary and secondary research capabilities. Our global network consists of offices in every major pharmaceutical market and clinical trial initiative around the world.
GlobalReach BI is a leading Strategic Intelligence Firm fully dedicated to the Life Science industry, located in the US and Europe. Our mission is to support the development of new patient treatments as well as facilitating their market launch through customized intelligence.
To do so, our clients, ranging from Top 10 Pharma Corporate to Biotech & MedTech companies, are trusting us in delivering the latest analysis and insights from the current trends in development as well as commercial strategies deployed by the competition.
Our Pharma clients have guided us, with their feedback, in integrating new AI technology to consolidate both secondary and primary intelligence via SPRING Portal. We are unique in combining customized intelligence with easy searching & retrieval for all your internal stakeholders, freeing you to carry out most valuable functions.
inPhronesis offers clients a streamlined interface (inVision) with custom functionality for business intelligence. inVision is a distinctive competitive intelligence portal with specific modules for medical conferences, clinical trial data, drug landscapes, and timelines. Empower your team with inVision…Organize, Share, Evaluate, and Visualize Your Data.
Providing expertise to optimize clinical development, commercialization and launch success
At Two Labs, our Market Intelligence team (formerly Pennside Partners) provides strategy and business insights to Global pharma and biotech companies seeking competitive intelligence and marketing landscape information.
SAI, established over 30 years ago, has a focused vision of providing clients with a new standard of decision support grounded in an intensive field oriented business research methodology, The heart of our value proposition remains our global team of over 300 professionals and their unwavering commitment to excellence and the success of our clients. We are passionate about one thing: helping you win in the market.
WNS (Holdings) Limited (NYSE: WNS) is a leading Business Process Management (BPM) company. WNS combines deep industry knowledge with technology, analytics and process expertise to co-create innovative, digitally led transformational solutions with over 375 clients across various industries. WNS delivers an entire spectrum of BPM solutions including industry-specific offerings, customer experience services, finance and accounting, human resources, procurement, and research and analytics to re-imagine the digital future of businesses. As of December 31, 2021, WNS had 49,610 professionals across 55 delivery centers worldwide including facilities in China, Costa Rica, India, the Philippines, Poland, Romania, South Africa, Spain, Sri Lanka, Turkey, the United Kingdom, and the United States.